Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

McLean Hospital partners with Rippl Care to address mental health needs of seniors with dementia

To address a crisis of unmet mental health needs among seniors with dementia and their family caregivers amid a shortage of mental health providers with expertise treating this population, McLean Hospital, a member of Mass General Brigham, has entered into an agreement to offer strategic advisory services and professional education to Rippl Care.

9 Oct 2023

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

The overlap in clinical and magnetic resonance imaging (MRI) findings between Alzheimer's disease and glaucoma.

9 Oct 2023

Groundbreaking research may provide hope to better understand and prevent Alzheimer’s disease

As of 2020, approximately 5.8 million Americans suffer from Alzheimer’s disease, but recent groundbreaking research may provide hope to better understand and potentially prevent this devastating condition.

9 Oct 2023

Graphene oxide offers a promising new approach to treating Alzheimer's disease

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer’s patients. Researchers at Chalmers University of Technology, have now shown that yeast cells that accumulate these misfolded amyloid peptides can recover after being treated with graphene oxide nanoflakes.

9 Oct 2023

UK's first-of-its-kind total-body PET imaging platform could enhance quality and speed of drug discovery

A partnership between Medicines Discovery Catapult (MDC), the Medical Research Council (MRC) and Innovate UK will deliver scientific breakthroughs with the launch of the UK's first-of-its-kind national total-body positron emission tomography (PET) imaging platform for drug discovery

9 Oct 2023

Non-invasive eye exam could be a valuable tool for early detection of cerebral small vessel disease

A research team led by the Keck School of Medicine of USC has discovered that a non-invasive eye exam may be a possible tool for screening Black Americans and other people from underdiagnosed and high-risk populations for cerebral small vessel disease, a major contributor to cognitive impairment and dementia.

6 Oct 2023

Researchers identify two main pathways involved in Alzheimer's disease

Dementia, which includes Alzheimer's disease, currently affects around 1.8 million people in Germany. The exact cause has not yet been clarified, but genetic factors play a significant role in the development of the disease.

6 Oct 2023

Breakthrough antibody therapy targets Alzheimer's risk gene, offers hope for effective treatment

Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs).

6 Oct 2023

Study helps explain how the brain adapts during a critical period of adulthood

Developing brains become shaped by the sights, sounds, and experiences of early life. The brain's circuits grow more stable as we age.

5 Oct 2023

New antibody shows promise in reducing tau proteins associated with Alzheimer's disease

A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer's disease.

5 Oct 2023

COVID-19 and COVID-19 vaccination have negligible effects on migraine severity, research shows

Research published in the European Journal of Neurology indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity.

5 Oct 2023

Exercise prevents the incidence of dementia in older people with osteoarthritis

The potential of minimal exercise (MAE) to prevent dementia.

5 Oct 2023

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early detection of neurodegenerative diseases at the recent 6G-enabled sustainable society event.

4 Oct 2023

Graphene oxide nanoflakes may help treat Alzheimer's disease

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer's patients.

4 Oct 2023

Study links high and low levels of "good" cholesterol with dementia risk

Having either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increased risk of dementia in older adults, according to a study published in the October 4, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

4 Oct 2023

Trametinib: Potential therapeutic game-changer for Alzheimer's disease

Researchers developed the ATRIVIEW® platform to screen for molecules that promote differentiation neural stem cells (NSCs).

4 Oct 2023

Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression

Researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2).

4 Oct 2023

Walking and Mediterranean diet may be the ticket to reducing dementia risk

The study explores the MedWalk intervention, promoting a Mediterranean-style diet and regular walking, to potentially slow cognitive decline in older adults without existing impairments. Despite COVID-19 disruptions, progress with 157 participants suggests this approach, rooted in psychosocial techniques, could offer a lifestyle-based deterrent against dementia and cognitive deterioration.

4 Oct 2023

Study addresses possible associations between chronic stress, mild cognitive impairment and Alzheimer's

Researchers from Karolinska Institutet have published a study in Alzheimer's Research & Therapy that addresses possible associations between chronic stress, mild cognitive impairment and Alzheimer's disease.

3 Oct 2023

Microglial states and their impact on Alzheimer's disease

Researchers examined 152,459 microglial transcriptomes from 443 individuals, identifying 12 transcriptional states and their relationship to Alzheimer's disease.

3 Oct 2023

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

McLean Hospital partners with Rippl Care to address mental health needs of seniors with dementia

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

Groundbreaking research may provide hope to better understand and prevent Alzheimer’s disease

Graphene oxide offers a promising new approach to treating Alzheimer's disease

UK's first-of-its-kind total-body PET imaging platform could enhance quality and speed of drug discovery

Non-invasive eye exam could be a valuable tool for early detection of cerebral small vessel disease

Researchers identify two main pathways involved in Alzheimer's disease

Breakthrough antibody therapy targets Alzheimer's risk gene, offers hope for effective treatment

Study helps explain how the brain adapts during a critical period of adulthood

New antibody shows promise in reducing tau proteins associated with Alzheimer's disease

COVID-19 and COVID-19 vaccination have negligible effects on migraine severity, research shows

Exercise prevents the incidence of dementia in older people with osteoarthritis

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Graphene oxide nanoflakes may help treat Alzheimer's disease

Study links high and low levels of "good" cholesterol with dementia risk

Trametinib: Potential therapeutic game-changer for Alzheimer's disease

Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression

Walking and Mediterranean diet may be the ticket to reducing dementia risk

Study addresses possible associations between chronic stress, mild cognitive impairment and Alzheimer's

Microglial states and their impact on Alzheimer's disease

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in